An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
- 13 November 2008
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 135 (5), 852-864
- https://doi.org/10.1016/j.cell.2008.09.061
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Defining the blueprint of the cancer genomeCarcinogenesis: Integrative Cancer Research, 2008
- Translating insights from the cancer genome into clinical practiceNature, 2008
- Replication stress induces tumor-like microdeletions in FHIT /FRA3BProceedings of the National Academy of Sciences of the United States of America, 2008
- Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancerProceedings of the National Academy of Sciences of the United States of America, 2007
- The Transcriptional Repressor Glis2 Is a Novel Binding Partner for p120 CateninMolecular Biology of the Cell, 2007
- Patterns of somatic mutation in human cancer genomesNature, 2007
- Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomasNature, 2007
- Identification and Validation of Oncogenes in Liver Cancer Using an Integrative Oncogenomic ApproachCell, 2006
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005
- Second-generation shRNA libraries covering the mouse and human genomesNature Genetics, 2005